Michelle Ross, Stempoint Capital, joins 'Closing Bell' to discuss Eli Lilly after the stock saw a slight dip after rallying.
- Күн бұрын
Biotech stocks will get a tailwind from rate cuts, says Stempoint's Michelle Ross
- Рет қаралды 6,548
Michelle Ross, Stempoint Capital, joins 'Closing Bell' to discuss Eli Lilly after the stock saw a slight dip after rallying.
Пікірлер: 12